Taken together, our data suggest that PRMT1-mediated meR342-EZH2 inhibits SUZ12 binding with EZH2 by preventing AMPKα1-mediated pT311-EZH2 in breast cancer. The gene discussed is PRMT1; the disease is breast cancer.